Caption Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 550 |
|
|
2025
Q1 | – | Sell |
-21,900
| Closed | -$601K | – | 574 |
|
|
2024
Q4 | $601K | Sell |
21,900
-38,100
| -64% | -$1.05M | 0.01% | 269 |
|
|
2024
Q3 | $1.53M | Sell |
60,000
-346,000
| -85% | -$8.81M | 0.02% | 124 |
|
|
2024
Q2 | $10.3M | Buy |
406,000
+95,566
| +31% | +$2.42M | 0.16% | 13 |
|
|
2024
Q1 | $9.6M | Buy |
+310,434
| New | +$9.6M | 0.15% | 16 |
|
|
2023
Q4 | – | Sell |
-90,600
| Closed | -$2.39M | – | 486 |
|
|
2023
Q3 | $2.39M | Buy |
+90,600
| New | +$2.39M | 0.04% | 69 |
|
|
2023
Q2 | – | Sell |
-46,817
| Closed | -$776K | – | 392 |
|
|
2023
Q1 | $776K | Buy |
+46,817
| New | +$776K | 0.02% | 135 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 472 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 545 |
|
|
2022
Q2 | – | Sell |
-20,000
| Closed | -$203K | – | 527 |
|
|
2022
Q1 | $203K | Sell |
20,000
-164,651
| -89% | -$1.67M | ﹤0.01% | 394 |
|
|
2021
Q4 | $3.08M | Buy |
+184,651
| New | +$3.08M | 0.03% | 127 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 556 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 446 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 404 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 336 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 365 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 329 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 340 |
|